Most Popular Products
Thymosin alpha 1 China
10.0 USD ($)/Piece
Product Details:
- Solubility It is slightly soluble or soluble in water, readily soluble in acidic peptide-solubilizing agents such as trifluoroacetic acid (TFA), and insoluble in common organic solvents such as acetonitrile and diethyl ether.
- Poisonous NO
- Molecular Formula C129H215N33O55
- Ingredients Thymosin alpha 1
- Properties Thymosin alpha 1 (often referred to as Thymalfasin in its synthetic analog form) is a 28-amino-acid peptide derived from the thymus gland. It possesses properties such as bidirectional immunomodulation and anti-inflammatory activity. 1. Basic Physicochemical Properties Molecular Structure: A small, naturally occurring peptide composed of 28 amino acid residues. Synthetic Form: The Thymalfasin used clinically is chemically and spatially identical to the naturally occurring human thymosin alpha 1. Route of Administration: Typically administered via subcutaneous injection. 2. Pharmacological and Immunomodulatory Properties T-cell Regulation: Stimulates peripheral blood lymphocytes, promoting the maturation and proliferation of T lymphocytes. Cytokine Induction: Enhances the secretion of lymphokines such as interferon-alpha (IFN- ), interferon-gamma (IFN- ), interleukin-2 (IL-2), and interleukin-3 (IL-3) by T cells, and increases the expression of lymphokine receptors on cell surfaces. Innate Immune Activation: Acts as an agonist for Toll-like receptors 2 and 9 (TLR-2 and TLR-9), helping to regulate immune homeostasis. NK Cell Activation: Promotes the recruitment of NK cell precursors and enhances their cytotoxicity. Anti-inflammatory and Antioxidant Effects: Helps mitigate excessive inflammatory responses and reduces damage caused by oxidative stress. 3. Clinical Applications Chronic Viral Infections: Frequently used in the treatment of conditions such as chronic hepatitis B and AIDS. Immunodeficiency and Adjuvant Therapy: Employed for congenital immunodeficiencies, sepsis, and as an adjunct in cancer treatment; also serves as an immune-enhancing adjuvant for vaccines. Mitigation of Chemotherapy/Radiotherapy Toxicity: Can improve outcomes for patients with compromised immune function and alleviate the immunosuppression induced by certain medical treatments.
- Smell Other
- Density 1.360 0.06 Gram per cubic centimeter(g/cm3)
- Click to View more
X
Thymosin alpha 1 China Price And Quantity
- 10 Piece
- 10.0 USD ($)/Piece
Thymosin alpha 1 China Product Specifications
- Thymosin alpha 1
- Thymosin alpha 1 (often referred to as Thymalfasin in its synthetic analog form) is a 28-amino-acid peptide derived from the thymus gland. It possesses properties such as bidirectional immunomodulation and anti-inflammatory activity. 1. Basic Physicochemical Properties Molecular Structure: A small, naturally occurring peptide composed of 28 amino acid residues. Synthetic Form: The Thymalfasin used clinically is chemically and spatially identical to the naturally occurring human thymosin alpha 1. Route of Administration: Typically administered via subcutaneous injection. 2. Pharmacological and Immunomodulatory Properties T-cell Regulation: Stimulates peripheral blood lymphocytes, promoting the maturation and proliferation of T lymphocytes. Cytokine Induction: Enhances the secretion of lymphokines such as interferon-alpha (IFN- ), interferon-gamma (IFN- ), interleukin-2 (IL-2), and interleukin-3 (IL-3) by T cells, and increases the expression of lymphokine receptors on cell surfaces. Innate Immune Activation: Acts as an agonist for Toll-like receptors 2 and 9 (TLR-2 and TLR-9), helping to regulate immune homeostasis. NK Cell Activation: Promotes the recruitment of NK cell precursors and enhances their cytotoxicity. Anti-inflammatory and Antioxidant Effects: Helps mitigate excessive inflammatory responses and reduces damage caused by oxidative stress. 3. Clinical Applications Chronic Viral Infections: Frequently used in the treatment of conditions such as chronic hepatitis B and AIDS. Immunodeficiency and Adjuvant Therapy: Employed for congenital immunodeficiencies, sepsis, and as an adjunct in cancer treatment; also serves as an immune-enhancing adjuvant for vaccines. Mitigation of Chemotherapy/Radiotherapy Toxicity: Can improve outcomes for patients with compromised immune function and alleviate the immunosuppression induced by certain medical treatments.
- Other
- 1.360 0.06 Gram per cubic centimeter(g/cm3)
- It is slightly soluble or soluble in water, readily soluble in acidic peptide-solubilizing agents such as trifluoroacetic acid (TFA), and insoluble in common organic solvents such as acetonitrile and diethyl ether.
- NO
- C129H215N33O55
- Research Grade
- Freezer
- Pharmaceutical
- Powder
- Peptides
- Thymosin alpha-1 (a synthetic analog often referred to as thymalfasin; brand names include Zadaxin) is a 28-amino-acid peptide primarily used for immunomodulation and enhancing the body s resistance. Primary Uses and Clinical Applications Chronic Viral Infections: Approved in over 35 countries for the treatment of chronic hepatitis B and chronic hepatitis C, it aids in viral clearance and the regulation of immune responses. Adjunctive Cancer Therapy: Used as an adjuvant to chemotherapy or immunotherapy to mitigate chemotherapy-induced immunosuppression and improve patient outcomes (e.g., in non-small cell lung cancer). Severe Infections and Sepsis: Employed in cases of sepsis, HIV/AIDS, and certain severe infections (such as lymphocytopenia associated with severe COVID-19) to help restore T-cell counts. Immune Deficiency and Anti-Aging Support: In some countries, it is used in clinical or anti-aging/wellness settings to address reduced resistance resulting from aging or compromised immune function. Administration and Typical Dosing (Reference Regimen) Route of Administration: Typically administered via subcutaneous (SubQ) injection; this can be performed at home under a physician s guidance or in a clinical setting. Common Dosage and Frequency: The standard adult subcutaneous dose is approximately 1.5 mg, typically administered once every 3 days, or 2 3 times per week. For acute or short-term viral infections, the treatment course is generally around 2 weeks; for complex immunomodulatory needs such as chronic hepatitis, HIV, or cancer the treatment course often lasts 3 months or longer.
- 18 Months
- 99.00%
- other
- 62304-98-7
- 2937190099
- Odorless
- 4.2
- White powder
- 1592732-453-0
- 1.563
- 3108.28 Drams (dr)
Thymosin alpha 1 China Trade Information
- Shenzhen or Guangzhou
- Telegraphic Transfer (T/T), Western Union
- 10000 Piece Per Week
- 5 Days
- Yes
- Sample costs shipping and taxes has to be paid by the buyer
- 10 vials per kit
- Australia, North America, Western Europe, Asia
- ISO9001, GMP
Product Description
Thymosin alpha 1 (T1)also known as thymosin-28 peptide or thymalfasinis a naturally occurring immunomodulatory polypeptide composed of 28 amino acids. It was first discovered in the 1970s by the scientist Allan Goldstein and his team, who isolated it from the thymus gland of a calf.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Peptide Preparations' category
Quick Inquiry
Contact Details
DALIAN HANDOM CHEMICALS CO.,LTD.
RM702, Unit 1, Building 21, Liuhe Road, Ganjingzi Dist,Dalian - 116091, Liaoning, China
Phone :--+8615840669648
Send InquiryE-mail us : export@handom-chem.com
 |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |
